Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pelvic Neoplasms 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Mesothelioma 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Leiomyoma 1 Colonic Polyps 1 Colonic Neoplasms 1 Chylous Ascites 1 Carcinoma, Non-Small-Cell Lung 1 Adenomyosis 1 Abdominal Neoplasms 1

Interventions

Fluorouracil 218 Leucovorin 201 Oxaliplatin 191 Irinotecan 148 Bevacizumab 107 Capecitabine 93 Cetuximab 89 Folfox protocol 54 Chemotherapy, Adjuvant 34 Panitumumab 30 pembrolizumab 23 Nivolumab 22 Colonoscopy 22 Gemcitabine 20 Magnetic Resonance Spectroscopy 19 Floxuridine 19 IFL protocol 18 Celecoxib 18 Radiotherapy 17 Neoadjuvant Therapy 17 Early Intervention, Educational 17 Drug Therapy 17 Laparoscopy 14 Cyclophosphamide 14 Counseling 14 trifluridine tipiracil drug combination 13 regorafenib 13 XELOX 13 Exercise 13 Erlotinib Hydrochloride 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Colonic Neoplasms × Iohexol × Clear all

NCT01200303 2015-08-05

ncCTC

Massachusetts General Hospital

Phase 2/3 Completed

Gastrointestinal

Colonic Neoplasms, Colonic Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡